Various concentrations of whey protein isolate (WPI), such as 0.1, 0.5, 1.0, 2.5, and 5.0%(w/v), containing 1.0%(w/v) eugenol were prepared by high speed homogenization to formulate nanoemulsions (NEs) and to investigate their antimicrobial activity. The results showed that particle size decreased according to increases in WPI concentration. Similarly, the ζ-potential value was reduced to a negative charge when using WPI concentrations >0.1%(w/v). In contrast, no significant differences in particle size were observed during 1 mon of storage, except for the 0.1%(w/v) WPI NE. The ζ-potential value depended on the increase in WPI concentration and storage duration, except for NE1 and NE5, suggesting that a low or high concentration of emulsifier was not effective for maintaining the droplet form of the eugenol NE. The results of an antibacterial effect investigation indicated that the growth of Escherichia coli was inhibited based on an increase in eugenol concentration in all NE formulations. Moreover, a membrane permeability study showed that total leakage content increased according to incubation time.
Introduction
Eugenol, the principal chemical component of clove oil from Eugenia aromatica, is a clear to pale yellow oily liquid that can also be extracted from certain essential oils from nutmeg, cinnamon, and bay leaf and is slightly soluble in water and soluble in organic solvents. It is known for its analgesic, local anesthetic, anti-inflammatory, and anti-bacterial effects. It belongs to the class of essential oils that is generally recognized as safe by the Food and Drug Administration. WHO announced estimates of acceptable daily intake of eugenol for man is 0-2.5 mg/kg body weight (Ali et al., 2005) . Eugenol is active against many pathogenic bacteria, such as E. coli, Listeria monocytogenes, Campylobacter jejuni, Salmonella enterica, Staphylococcus aureus, Lactobacillus sake, and Helicobacter pylori ( . The major problem with eugenol is its low solubility in aqueous phases. Solubilizing eugenol in a surfactant may overcome this limitation. An emulsion is a colloidal dispersion of two immiscible liquid phases that is present as small spherical droplets (a dispersed phase) in the other continuous phase.
Emulsion-based systems are being increasingly used as delivery systems to encapsulated hydrophobic bioactive compounds, may split up into either conventional emulsions (diameter >100 nm) or nanoemulsions (diameter <100 nm) depending on the dimensions of the droplets they contain (Ziani et al., 2011) .
Food grade emulsions formed from essential oils are commercially attractive because of the potential health benefits associated with their consumption (Burdge and Calder, 2006 ; Kolanowski and Laufenberg, 2006) . Many food products appear in the form of oil-in-water emulsions in which the oil droplets are usually stabilized by proteins acting as emulsifiers.
Whey proteins are widely used due to their excellent emulsification properties. Whey proteins consist of several types of globular proteins, such as α-lactalbumin (ALB), β-lactoglobulin (BLG), bovine serum albumin, and immunoglobulins. BLG is the main whey protein component and its principal gelling agent. Both ALB and (Kinsella, 1984) . Whey proteins can be applied as wall material in nanoparticles. Nanoparticles are dense polymeric network matrix systems in which an active molecule may be dispersed throughout the matrix (Nakache et al., 2000) . Because nanoparticles are submicron and sub-cellular in size, they are versatile for targeted, site-specific delivery purposes (Vinogradov et al., 2002) , as they can penetrate circulating systems and target sites. Nanoparticles offer the ability to entrap drugs or bioactive compounds within but not chemically bound to them. In food emulsions, whey protein aids in forming and stabilizing the system by adsorbing at the oil droplet surface where it forms a film and protects the system against coalescence, thereby improving stability.
Many studies have shown the antimicrobial properties of nanoemulsions formulated with antimicrobial substances. Antimicrobial nanoemulsions are novel water-inoil formulations that are stabilized by adding small amounts of surfactants. Among nanoencapsulation systems for the delivery of bioactive compounds, nanoemulsions are mainly suitable for food applications, because can be created with food ingredients (Donsì et al., 2011) . However, limited information is available for their biological activity in nanoemulsion prepared with whey protein. Therefore, the objective of this study was to determine the characteristics of eugenol-incorporated with whey protein nanoemulsions such as, particle size, ζ-potential, and surface tension as well as their stability to determine if they could be used as antimicrobials in food systems. 
Materials and Methods

Materials
Nanoemulsion preparation
Nanoemulsions were prepared following the information provided in Table 1 . Briefly, WPI solution at various condition 0.1 to 5.0 wt% concentration was prepared by dispersed WPI powder as emulsifier into distilled water, then stirred at least 3 h. Eugenol, 1.0 wt% was added to the WPI solutions. Samples were homogenized in a highspeed homogenizer (Ultra-Turrax ® T25, IKA Labotechnik, Germany) at 11,000 rpm for 5 min.
Determination of particle size and ζ-potential
The sizes of the eugenol-nanoemulsions were measured by photon correlation spectroscopy (Nano-ZS90 nanoseries, Malvern Instruments, UK). For the size measurements, all formulations were diluted with 1 mL of distilled water. Particle diameter, the polydispersity index, and ζ-potential values were obtained in triplicate at 25 o C.
Surface tension determination
Surface tensions of the eugenol-WPI nanoemulsions were determined using a tensiometer (KSV Sigma 703D, USA). This method measures the maximum weight of a liquid that is lifted by a ring, which is pulled out of a liquid surface or interface. The ring is above the surface and the balance is zeroed. The ring touches the surface and becomes wetted, resulting in a positive force. Then, a negative force is applied to the ring as it is pushed through the surface into the liquid. The maximum force needed to pull the ring from the liquid is proportional to the surface tension of the liquid. The greater the force needed, the greater the surface tension. All tests were carried out in triplicate. 
Preparation of antimicrobial agents
Suspensions of the antimicrobial agents to be tested were prepared prior to use by adding pure eugenol or eugenol-WPI nanoemulsions to sterile TSB containing 5% DMSO or TSB, respectively, followed by vortex mixing.
Antimicrobial activity of eugenol and the eugenol-WPI nanoemulsions
Determination of minimum inhibitory concentration (MIC) of nanoemulsions MIC estimation was carried out by the broth dilution method (Van der Berghe and Vlietinck, 1991). Pure eugenol and the nanoemulsions were prepared in a concentration range from 1 µg/mL to 1 mg/mL. Test tubes of TSB, prepared as described above, were inoculated with E. coli (-10 8 CFU/mL) and incubated for 24 h at 37 o C. Following the incubation, 100 µL aliquots of the medium were plated onto PCA to determine viable cell counts.
Assay for antimicrobial activity of the eugenol-WPI nanoemulsions during storage
Time course viability studies of the eugenol-WPI nanoemulsions were set up. The appropriate concentration of eugenol in nanoemulsions was prepared in TSB flasks, which were inoculated with E. coli at the same concentration as the above MIC tests, but the broths were sampled at different times to check cell viability.
In vitro eugenol release study The in vitro eugenol release study was conducted based on a standard curve. Distilled water was added to eugenol-WPI nanoemulsion. Eugenol release was monitored as a function of time at 25 o C. A 5 mL aliquot of sample was withdrawn and centrifuged at 3,000 rpm for analysis at desired time intervals. The supernatant was then removed and replaced with the same amount of distilled water. Eugenol concentration was determined by measuring the absorbance at 284 nm with a UV-visible spectrophotometer (Optizen, Mecasys, Korea). Eugenol release was calculated by comparing it with the initial concentration of eugenol entrapment with WPI. sity of approximately log 8 CFU/mL. Bacteria in sterile normal saline were incubated for different times (30, 60, 90, 120, and 180 min) with various water dilutions of the nanoemulsions. An incubation with sterile normal saline was used as a control. The mixture was filtered through a 0.2 µm syringe filter (Whatman GD/X syringe filters cellulose acetate membrane, Sigma-Aldrich, USA) to remove the bacterial cells. The filtrate was then diluted appropriately, and the optical density at 260 nm was recorded (UV-visible spectrometer at room temperature, 25 o C). At the absorbance of 260 nm, it is wavelength for detect DNA or RNA leakage of cell membrane whereas, the wavelength 280 nm is applied for the protein detection.
Bacterial membrane permeability
Statistical analysis
The data were analyzed with an analysis of variance using the SAS statistical program 9.1 (SAS Institute, USA). Differences between means were compared using Duncan's multiple-range test, and correlations between independent variables and measured values were calculated with Pearson's correlation coefficients. Each treatment had three replicate determinations.
Results and Discussion
Particle size measurements Figs. 1 and 2 show the particle sizes and the ζ-potentials of the nanoemulsions. The mean nanoemulsion diameter in the absence of an antimicrobial was in the range of 100-350 nm, and the nanoemulsion particle size decreased according to the increase in the WPI concentration. The higher concentration of surfactant results in productions of smaller particle size. This is owing to better stabilization of internal droplets with increase of surfactant concentration preventing coalescence (Pachuau and Mazumder, 2009 ). Surfactant surface coverage can be used to explain the relationship between mean size of nanoemulsion and WPI concentration. At low WPI concentration there is deficient surfactant, newly formed droplets agglomerate. Increasing surfactant concentration results in a large decrease in particle size because more surfactant for stabilizing the newly formed droplets (Kentish et al., 2008).
However, the decreases of the size were not significantly different (p≥0.05) when using WPI was higher than 1%. The rate of the decrease in emulsion droplet size with excess increasing surfactant concentration decreases, because the concentration of surfactant in the bulk is suf-ficient to allow rapid diffusion and adsorption of the surfactant to newly formed droplets. Any further increase in surfactant concentration only leads to a small increase in surfactant diffusion (Kentish et al., 2008) .
Similarly, ζ-potential was reduced to a negative charge dependant on increasing WPI concentration. The particle size distribution of the formulation was homogeneous with a narrow peak in all cases, except for the nanoemulsion 1 formulation, which is shown in Fig. 3 , and the low polydispersity index values (data not shown). In contrast, no difference in particle size was observed for any of the formulations during storage for 1 month at 25 o C except for the 0.1% (w/v) WPI nanoemulsion (p < 0.05). The ζ-potential differed slightly depending on the formulation and storage duration.
Effect of WPI concentration on the surface tension of eugenol-WPI nanoemulsions
Interfacial surface tension plays an important role ensuring droplet stability. The effect of various WPI concentrations on the surface tension of the eugenol-WPI nanoemulsions during storage at ambient temperature for 30 d is shown in Table 2 . The result showed that the sur- 
NE1 (A), NE2 (B), and NE3 (C)
face tension of the eugenol-WPI nanoemulsions decreased slightly based on the increase in WPI concentration. Furthermore, no significant differences in surface tension during ambient-temperature storage for 30 d occurred in any of the formulations, suggesting that WPI reduced the interfacial tension between oil and water by adsorption at the liquid-liquid interface. This result was in good agreement with Scherze and Muschiolik (Scherze et al., 2001) , who reported that interfacial tension decreased with increasing whey protein concentration.
MIC
The antimicrobial activity of pure eugenol was investigated in this experiment. The minimum concentration of the antimicrobial compounds required to inhibit the growth of E. coli was determined. The results showed that 0.5 mg/mL of pure eugenol was the MIC for E. coli (data not shown). A similar trend was found in a study by Hili et al. (Hili et al., 1997) . Their results demonstrated that 0.5 mg/mL leaf oil (eugenol oil) completely inhibited E. coli growth. Another report found that the MIC of eugenol against E. coli was 0.1% (Oussalah et al., 2007) .
Effect of eugenol-WPI nanoemulsions on microbial growth during storage
The viability study is presented in terms of log CFU/ mL. Figs. 4 through 8 showed the effects of different eugenol concentrations in various WPI concentrations against microbial growth during 24 h. All formulations showed a beneficial bacteriostatic effect against Gramnegative E. coli. This finding was similar to other studies that showed bacteriostatic effects on Gram-negative bacteria (Rhim et al., 2006; Sothornvit et al., 2010) . E. coli growth in the 0.3 mg/mL eugenol nanoemulsion was similar to that of the control, whereas the rate of inhibition in the bacterial-cell cultures increased at 0.3 mg/mL eugenol and was higher in samples with 0.5 and 0.8 mg/mL eugenol, providing clear evidence of a true biocidal effects at 0.8 mg/mL. Furthermore, at a concentration of Average±SD (n = 3); NE, nanoemulsion Means with different capital letters are significantly different (p<0.05) when compared within the same formulation. Mean with different small letters are significantly different (p<0.05) when compared between formulations. 
)
NE1 means nanoemulsion of eugenol (1.0%) with whey protein isolate (0.1%). 
NE2 means nanoemulsion of eugenol (1.0%) with whey protein isolate (0.5%). 0.5 mg/mL eugenol (eugenol-WPI nanoemulsion 3), bacterial growth decreased continuously from 7 log to 5 log CFU/ml for up to 16 h, after which slower growth was observed, indicating that this formulation was the most effective for inhibiting E. coli growth. From these results showed the bacteriostatic activity of eugenol-WPI nanoemulsions was not significantly different when compared with pure eugenol. The MIC (bacteriostatic activity) value of antimicrobial agents encapsulated in nanoemulsions resulted always lower or equal to pure compounds (Donsì et al., 2011) .
Encapsulation of essential oil at the nanoscale is able to enhance the antimicrobial activity by increase the concentration of the bioactive compounds in food areas where microorganisms are preferably located (Donsì et al., 2011; Weiss et al., 2009 ). On the other hand, in another study, the antimicrobial of bioactive compounds was not improved by encapsulation system. The chitosan incorporate in emulsion system, which composed of castor oil and medium-chain triglycerides stabilized by Poloxamer 188, slightly less active than free chitosan (Jumaa et al., 2002) . Furthermore, the formation of various preservatives were contained in emulsion system influenced instability of the emulsion and led to insufficient activities against microorganisms. Therefore, the effective of antimicrobials of essential oil depend on the physicochemical properties of the emulsions and the location of the antimicrobials in the emulsion system (Sznitowska et al., 2002) .
In addition to essential oil concentration is the main parameter in antimicrobial efficiency, several factors governing this limitation should be carefully considered when designing and selecting a suitable nanoencapsulation system for antimicrobials include; polarity of essential oil, temperature and pH (Weiss et al., 2009 ).
Eugenol release from WPI nanoemulsions
The eugenol release profiles from the WPI nanoemulsions are shown in Fig. 9 . The eugenol release rate was clearly independent of WPI concentration. The release characteristics show that a high amount of eugenol was released within 8 h of duration time in all the samples. Then, small amount of eugenol was released till the end of incubation time. In addition, the eugenol release rate from nanoemulsion 3 was substantially faster than that of the other formulations. Release study result was consis- 
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NE3 means nanoemulsion of eugenol (1.0%) with whey protein isolate (1.0%). 
NE4 means nanoemulsion of eugenol (1.0%) with whey protein isolate (2.5%). 
NE5 means nanoemulsion of eugenol (1.0%) with whey protein isolate (5.0%).
tent with the antimicrobial activity result, showing that nanoemulsion 3 was the optimum formulation to inhibit E. coli growth. Because of the nanoemulsion 3 was the highest amount of eugenol released, therefore, this result is supported that why this formulation was the best effective of antimicrobial activity. It was also observed that the eugenol is released faster initially and at the end of the study, the nanoemulsions are left with residue eugenol. This suggests that there will be antimicrobial activity shown by the nanoemulsions even after 24 hours. This result was in good agreement with Shanmugasundaram (Shanmugasundaram et al., 2011).
Activity against membrane permeability in bacteria A membrane permeability assay was performed to explore whether the plasma membrane is disrupted when an effective nanoemulsion concentration binds to the bacterial cell membrane. If a bacterial membrane is damaged, leakage of cytoplasmic constituents from the cell can be monitored. The amount of DNA and RNA released from cytoplasm can be detected by measuring the absorbance at 260 nm. Total nucleotide leakage from bacterial cells as a function of incubation time with the different nanoemulsion formulations is plotted in Fig. 10 . For all formulations, the results showed that the amount of total leakage was dependent on incubation time. Leakage increased quickly within 30 min when the bacteria were treated with either 5-fold or 10-fold diluted nanoemulsions (all formulations) but showed only a slight increase thereafter. Additionally, nucleotide leakage in the cells treated with 5-fold diluted nanoemulsions was higher than that of the 10-fold diluted nanoemulsions. Furthermore, the amount of nucleotide leakage depended on an increase in the WPI concentration.
The results demonstrated that the nanoemulsion particles were a mean size of approximately 300 nm. No differences in particle size were found among the formulations during 1 month of storage at 25 o C, except for the 0.1%(w/v) WPI nanoemulsion. The ζ-potential varied slightly depending on storage duration, indicating that adding eugenol to WPI leads to the spontaneous formation of a stable nanoemulsion. The results of antimicrobial tests against E. coli suggested that E. coli was inhibited based on increases in the eugenol concentration, and that the bacterial growth was inhibited completely at 0.8 mg/mL in all formulations, demonstrating the effective bactericidal activity of the eugenol-WPI nanoemulsions. A membrane permeability study showed that the interaction between the antimicrobial nanoemulsions and bacterial membrane decreased bacterial cell-surface hydrophobicity and induced the release of nucleotides at 260 nm. Taken together, good antimicrobial activity was demonstrated by incorporating eugenol into WPI nanoemulsions. 
